目錄:MedChemExpress LLC>>生化試劑>> ADH-503 | MCE
參考價(jià) | ¥ 550 |
參考價(jià) | ¥ 550 |
更新時(shí)間:2023-06-15 09:26:17瀏覽次數(shù):198評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,謝謝!
CAS | 2055362-74-6 | 純度 | 98.04% |
---|---|---|---|
分子量 | 524.65 | 分子式 | C??H??N?O?S? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 5 mg |
貨號(hào) | HY-15701B | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),,我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù),。
CAS No. : 2055362-74-6
產(chǎn)品活性:ADH-503 ((Z)-Leukadherin-1 choline) is an orally active and allosteric CD11b agonist. ADH-503 leads to the repolarization of tumor-associated macrophages, reduction in the number of tumor-infiltrating immunosuppressive myeloid cells, and enhances dendritic cell responses.
研究領(lǐng)域:Immunology/Inflammation
作用靶點(diǎn):Complement System
In Vitro: ADH-503 ((Z)-Leukadherin-1 choline; 4 μM; 8 days) reduces the numbers of total tumor-infiltrating CD11b+ cells and subsets of CD11b+ monocytes, granulocytes, eosinophils, and macrophages.
In Vivo: ADH-503 ((Z)-Leukadherin-1 choline; oral gavage; 30, 60, or 120 mg/kg; twice a day for 60 days) delayes tumor progression, leading to a significantly decreased tumor burden in time-point analysis and improved overall survival.
ADH-503 (oral gavage; 30, 100 mg/kg; twice a day; on days 1 and 5) has the mean half-life of 4.68 and 3.95 hours, a maximum concentration of 1716 and 2594 ng/mL and AUC0-t in the plasma of 6950 and 13962 ng.h/mL at 30 and 100 mg/kg dosing, respectively.
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Anti-Cancer Compound Library | Orally Active Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | FD-IN-1 | CP-447697 | Factor B-IN-2 | Ravulizumab | NRP1 antagonist 1 | Avacincaptad pegol | NRP1 antagonist 2 | EG00229 | Dexamethasone-d4 | Complement C1s-IN-1 | Complement C5-IN-1 | Pozelimab | Phaseoloidin | Pexelizumab | Avdoralimab | POT-4 TFA | EG01377 | Non-PEGylated/naked ARC186 | Certepetide | ATWLPPR Peptide TFA | Tesidolumab | Gefurulimab | Compstatin | Cyclosporin A | Cemdisiran, terminal sugar modification- | AMY-101 acetate | Factor D inhibitor 6 | BCX 1470
熱門產(chǎn)品線:重組蛋白 | 化合物庫(kù) | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點(diǎn)擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫(kù),,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑,、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng),;
• 產(chǎn)品種類涵蓋各種重組蛋白,,多肽,,常用試劑盒 ,,更有 PROTAC、ADC 等特色產(chǎn)品,,廣泛應(yīng)用于新藥研發(fā),、生命科學(xué)等科研項(xiàng)目;
• 提供虛擬篩選,,離子通道篩選,,代謝組學(xué)分析檢測(cè)分析,,藥物篩選等專業(yè)技術(shù)服務(wù),;
• 設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系;
• 提供 LC/MS,、NMR,、HPLC、手性分析,、元素分析等各項(xiàng)質(zhì)檢報(bào)告,,確保產(chǎn)品的高純度、高品質(zhì),;
• 產(chǎn)品的生物活性多經(jīng)各國(guó)客戶實(shí)驗(yàn)驗(yàn)證,;
• Nature, Cell, Science 等多種頂級(jí)期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,,為您提供*新的活性化合物,;
• 與世界各大制藥公司及著名科研機(jī)構(gòu)建立了長(zhǎng)期的合作。
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)